Search research articles
Contact Us
Filters
Showing results (71-80 of 109) with videos related to
Page
of 11
Sort By:
Cancer Immunology Research
|
February 7, 2020
B cell-Derived IL35 Drives STAT3-Dependent CD8<sup>+</sup> T-cell Exclusion in Pancreatic Cancer
Bhalchandra Mirlekar, Daniel Michaud, Samuel J Lee, et al.
Immunity
|
September 19, 2019
The Transcription Factor Bhlhe40 Programs Mitochondrial Regulation of Resident CD8<sup>+</sup> T Cell Fitness and Functionality
Chaofan Li, Bibo Zhu, Young Min Son, et al.
Biorxiv : the Preprint Server for Biology
|
March 31, 2025
PRAME Epitopes are T-Cell Immunovulnerabilities in <i>BRD4::NUTM1</i> Initiated NUT Carcinoma
Jeffrey L Jensen, Sara K Peterson, Shawn Yu, et al.
Frontiers in Oncology
|
February 8, 2021
Brain Tumor Microenvironment and Angiogenesis in Melanoma Brain Metastases
Dimitri G Trembath, Eric S Davis, Shanti Rao, et al.
Immunity
|
January 16, 2020
The Transcription Factor Bhlhe40 Programs Mitochondrial Regulation of Resident CD8<sup>+</sup> T Cell Fitness and Functionality
Chaofan Li, Bibo Zhu, Young Min Son, et al.
JCI Insight
|
November 19, 2020
Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinoma
Christopher G Wood, James E Ferguson, Joel S Parker, et al.
The Journal of Clinical Investigation
|
August 24, 2018
Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma
Christof C Smith, Kathryn E Beckermann, Dante S Bortone, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 19, 2023
Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors
Benjamin G Vincent, Danielle M File, Karen P McKinnon, et al.
JCI Insight
|
June 15, 2017
Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma
Peter J Siska, Kathryn E Beckermann, Frank M Mason, et al.
Nature Communications
|
May 24, 2024
Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer
Wolfgang Beckabir, Mi Zhou, Jin Seok Lee, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 109) with videos related to
Sort By:
Page
of 11
Cancer Immunology Research
|
February 7, 2020
B cell-Derived IL35 Drives STAT3-Dependent CD8<sup>+</sup> T-cell Exclusion in Pancreatic Cancer
Bhalchandra Mirlekar, Daniel Michaud, Samuel J Lee, et al.
Immunity
|
September 19, 2019
The Transcription Factor Bhlhe40 Programs Mitochondrial Regulation of Resident CD8<sup>+</sup> T Cell Fitness and Functionality
Chaofan Li, Bibo Zhu, Young Min Son, et al.
Biorxiv : the Preprint Server for Biology
|
March 31, 2025
PRAME Epitopes are T-Cell Immunovulnerabilities in <i>BRD4::NUTM1</i> Initiated NUT Carcinoma
Jeffrey L Jensen, Sara K Peterson, Shawn Yu, et al.
Frontiers in Oncology
|
February 8, 2021
Brain Tumor Microenvironment and Angiogenesis in Melanoma Brain Metastases
Dimitri G Trembath, Eric S Davis, Shanti Rao, et al.
Immunity
|
January 16, 2020
The Transcription Factor Bhlhe40 Programs Mitochondrial Regulation of Resident CD8<sup>+</sup> T Cell Fitness and Functionality
Chaofan Li, Bibo Zhu, Young Min Son, et al.
JCI Insight
|
November 19, 2020
Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinoma
Christopher G Wood, James E Ferguson, Joel S Parker, et al.
The Journal of Clinical Investigation
|
August 24, 2018
Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma
Christof C Smith, Kathryn E Beckermann, Dante S Bortone, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 19, 2023
Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors
Benjamin G Vincent, Danielle M File, Karen P McKinnon, et al.
JCI Insight
|
June 15, 2017
Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma
Peter J Siska, Kathryn E Beckermann, Frank M Mason, et al.
Nature Communications
|
May 24, 2024
Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer
Wolfgang Beckabir, Mi Zhou, Jin Seok Lee, et al.
Page
of 11